SYS6020 injection: Clinical Trials

1 trial of SYS6020 injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow SYS6020 injection: new trials by email Literature Review of SYS6020 injection trials Research Report on SYS6020 injection

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis
SYS6020 injection - Multiple Sclerosis
Phase 1 / Phase 2Not yet recruitingTongji Hospital252026-09-162026-08-10

Conditions studied

Multiple Sclerosis (1)  ·  Multiple Sclerosis, Chronic Progressive (1)

Sponsors

Tongji Hospital (1)

Countries

China (1)

Top investigators

Chuan Qin, MD (1)  ·  Daishi Tian, MD (1)  ·  Zhouping Tang, MD (1)